Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
Luna, Gustavo, Alping, Peter, Burman, Joachim, Fink, Katharina, Fogdell-Hahn, Anna, Gunnarsson, Martin, Hillert, Jan, Langer-Gould, Annette, Lycke, Jan, Nilsson, Petra, Salzer, Jonatan, Svenningsson,Journal:
JAMA Neurology
DOI:
10.1001/jamaneurol.2019.3365
Date:
October, 2019
File:
PDF, 313 KB
2019